Assignee
IPSEN PHARMA SAS
FR·49 granted patents·47 pending applications·321 citations·filing 2003–2025
Top patents by PatentIndex Score
96 records- 0194US8039435B2Melanocortin receptor ligandsIPSEN PHARMA SAS·Filed 2006·Granted Oct 18, 2011·15 cites·2 claims
- 0293US8377865B2Growth hormone releasing peptidesIPSEN PHARMA SAS·Filed 2008·Granted Feb 19, 2013·13 cites·12 claims
- 0392US7858789B2Derivatives of 4-aminopiperidine and their use as a medicamentIPSEN PHARMA SAS·Filed 2008·Granted Dec 28, 2010·16 cites·1 claims
- 0491US8034808B2Therapeutic compositions containing at least one pyrrolobenzodiazepine derivative and fludarabineIPSEN PHARMA SAS·Filed 2005·Granted Oct 11, 2011·128 cites·20 claims
- 0589US7576241B2Derivatives of amidines, their preparation, their use as medicaments and the pharmaceutical compositions containing themIPSEN PHARMA SAS·Filed 2005·Granted Aug 18, 2009·12 cites·6 claims
- 0688US9850280B2Melanocortin receptor ligandsIPSEN PHARMA SAS·Filed 2017·Granted Dec 26, 2017·3 cites·9 claims
- 0788US8349797B2Ligands of melanocortin receptorsIPSEN PHARMA SAS·Filed 2006·Granted Jan 8, 2013·11 cites·43 claims
- 0888US7932231B2Compositions and methods for stimulating gastrointestinal motilityIPSEN PHARMA SAS·Filed 2006·Granted Apr 26, 2011·10 cites·25 claims
- 0988US7816539B2Derivatives of benzimidazole and imidazo-pyridine and their use as medicamentsIPSEN PHARMA SAS·Filed 2009·Granted Oct 19, 2010·11 cites·6 claims
- 1085US8859729B2Growth hormone releasing peptidesIPSEN PHARMA SAS·Filed 2013·Granted Oct 14, 2014·4 cites·9 claims
- 1185US2026085092A1Melanocortin receptor ligandsIPSEN PHARMA SAS·Filed 2025·Application pending·0 cites
- 1284US10206968B2Process for the preparation of pharmaceutical compositions for the sustained release of somatostatin analogsIPSEN PHARMA SAS·Filed 2016·Granted Feb 19, 2019·2 cites·17 claims
- 1384US7517853B2Somatostatin-dopamine chimeric analogsIPSEN PHARMA SAS·Filed 2004·Granted Apr 14, 2009·19 cites·2 claims
- 1483US8952128B2Somatostatin-dopamine chimeric analogsIPSEN PHARMA SAS·Filed 2013·Granted Feb 10, 2015·5 cites·8 claims
- 1583US2024182519A1Melanocortin receptor ligands modified with hydantoinIPSEN PHARMA SAS·Filed 2023·Application pending·0 cites
- 1681US9409948B2Growth hormone releasing peptidesIPSEN PHARMA SAS·Filed 2014·Granted Aug 9, 2016·2 cites·7 claims
- 1781US8017637B2Inhibitors of cdc phosphatasesIPSEN PHARMA SAS·Filed 2005·Granted Sep 13, 2011·9 cites·24 claims
- 1881US7795284B24,7-dioxobenzothiazole-2-carboxamide derivatives, their preparation and their therapeutic usesIPSEN PHARMA SAS·Filed 2005·Granted Sep 14, 2010·9 cites·12 claims
- 1981US7662784B2Method for decreasing body weight using a somatostatin receptor agonistIPSEN PHARMA SAS·Filed 2005·Granted Feb 16, 2010·2 cites·10 claims
- 2081US2022127305A1Melanocortin receptor ligandsIPSEN PHARMA SAS·Filed 2022·Application pending·0 cites
- 2179US7763725B2Pyrimido-benzimidazole derivatives and the use thereof in the form of agonists and antagonists of melanocortin receptorsIPSEN PHARMA SAS·Filed 2005·Granted Jul 27, 2010·4 cites·21 claims
- 2278US7956075B2Derivatives of heterocycles with 5 members, their preparation and their use as medicamentsIPSEN PHARMA SAS·Filed 2007·Granted Jun 7, 2011·3 cites·18 claims
- 2378US2022339239A1Use of melanocortins to treat insulin sensitivityIPSEN PHARMA SAS·Filed 2022·Application pending·0 cites
- 2477US9096609B2Macrocyclic LRRK2 kinase inhibitorsIPSEN PHARMA SAS·Filed 2012·Granted Aug 4, 2015·5 cites·10 claims
- 2576US9370520B2Macrocyclic LRRK2 kinase inhibitorsIPSEN PHARMA SAS·Filed 2015·Granted Jun 21, 2016·3 cites·9 claims
- 2676US7977455B2Analogues of GLP-1IPSEN PHARMA SAS·Filed 2007·Granted Jul 12, 2011·1 cites·14 claims
- 2776US7897566B2Analogues of GLP-1IPSEN PHARMA SAS·Filed 2004·Granted Mar 1, 2011·8 cites·2 claims
- 2876US7638546B1Imidazolyl derivativesIPSEN PHARMA SAS·Filed 2007·Granted Dec 29, 2009·2 cites·4 claims
- 2976US2020347110A1Composition and Methods for Stimulating Gastrointestinal MotilityIPSEN PHARMA SAS·Filed 2019·Application pending·0 cites
- 3075US7589058B2Ghrelin analogsIPSEN PHARMA SAS·Filed 2003·Granted Sep 15, 2009·8 cites·16 claims
- 3174US9827286B2Use of melanocortins to treat insulin sensitivityIPSEN PHARMA SAS·Filed 2016·Granted Nov 28, 2017·1 cites·10 claims
- 3273US2021163536A1Melanocortin receptor ligands modified with hydantoinIPSEN PHARMA SAS·Filed 2021·Application pending·0 cites
- 3372US9499599B2Composition and methods for stimulating gastrointestinal motilityIPSEN PHARMA SAS·Filed 2015·Granted Nov 22, 2016·1 cites·24 claims
- 3472US9439943B2Use of melanocortins to treat insulin sensitivityIPSEN PHARMA SAS·Filed 2015·Granted Sep 13, 2016·1 cites·17 claims
- 3572US9296783B2Melanocortin receptor ligands modified with hydantoinIPSEN PHARMA SAS·Filed 2013·Granted Mar 29, 2016·1 cites·26 claims
- 3672US2020095281A1Melanocortin Receptor LigandsIPSEN PHARMA SAS·Filed 2019·Application pending·0 cites
- 3772US2009270341A1Product comprising a transduction inhibitor of heterotrimeric g protein signals combined with another anti-cancer agent for therapeutic use in the treatment of cancerIPSEN PHARMA SAS·Filed 2009·Application pending·0 cites
- 3871US7999061B2Catalytic lactide and glycolide (co)polymerization systemIPSEN PHARMA SAS·Filed 2008·Granted Aug 16, 2011·2 cites·15 claims
- 3971US7790680B2Stable pharmaceutical composition containing factor VIIIIPSEN PHARMA SAS·Filed 2003·Granted Sep 7, 2010·5 cites·7 claims
- 4070US2020017548A1Growth Hormone Releasing PeptidesIPSEN PHARMA SAS·Filed 2019·Application pending·0 cites
- 4169US2018305406A1Melanocortin Receptor LigandsIPSEN PHARMA SAS·Filed 2018·Application pending·0 cites
- 4267US10543249B2Pharmaceutical composition for a sustained release of lanreotideIPSEN PHARMA SAS·Filed 2014·Granted Jan 28, 2020·1 cites·7 claims
- 4367US2018105557A1Melanocortin Receptor LigandsIPSEN PHARMA SAS·Filed 2017·Application pending·0 cites
- 4467US2020360483A1METHOD FOR INHIBITING INFLAMMATION and PRO-INFLAMMATORY CYTOKINE/CHEMOKINE EXPRESSION USING A GHRELIN ANALOGUEIPSEN PHARMA SAS·Filed 2020·Application pending·0 cites
- 4565US10787696B2System for the assessment of protease activityIPSEN PHARMA SAS·Filed 2013·Granted Sep 29, 2020·0 cites·11 claims
- 4665US7754253B2Botulinum toxin for the treatment of reduction of hair growthIPSEN PHARMA SAS·Filed 2005·Granted Jul 13, 2010·4 cites·18 claims
- 4765US2019062374A1Melanocortin receptor ligands modified with hydantoinIPSEN PHARMA SAS·Filed 2018·Application pending·0 cites
- 4865US2017362275A1Growth Hormone Releasing PeptidesIPSEN PHARMA SAS·Filed 2017·Application pending·0 cites
- 4964US2019167754A1Process for the preparation of pharmaceutical compositions for the sustained release of somatostatin analogsIPSEN PHARMA SAS·Filed 2018·Application pending·0 cites
- 5064US2016368962A1Melanocortin Receptor LigandsIPSEN PHARMA SAS·Filed 2016·Application pending·0 cites
Showing the top 50 of 96 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →